These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [Risk factors of clinically significant portal hypertension in patients with compensated liver cirrhosis based on hepatic venous pressure gradient]. Jiang FR; Yan HD Zhonghua Gan Zang Bing Za Zhi; 2021 Oct; 29(10):995-1000. PubMed ID: 34814395 [No Abstract] [Full Text] [Related]
9. Assessment of the Performance of Non-invasive Criteria for the Evaluation of Clinically Significant Portal Hypertension in Patients with Compensated Advanced Chronic Liver Disease. Jindal A; Agarwal S; Sharma S; Kumar M; Saraya A; Sarin SK Dig Dis Sci; 2023 May; 68(5):2149-2157. PubMed ID: 36562888 [TBL] [Abstract][Full Text] [Related]
12. Non-invasive detection of portal hypertension by enhanced liver fibrosis score in patients with different aetiologies of advanced chronic liver disease. Simbrunner B; Marculescu R; Scheiner B; Schwabl P; Bucsics T; Stadlmann A; Bauer DJM; Paternostro R; Eigenbauer E; Pinter M; Stättermayer AF; Trauner M; Mandorfer M; Reiberger T Liver Int; 2020 Jul; 40(7):1713-1724. PubMed ID: 32358998 [TBL] [Abstract][Full Text] [Related]
13. The Sequential Application of Baveno VII Criteria and VITRO Score Improves Diagnosis of Clinically Significant Portal Hypertension. Jachs M; Hartl L; Simbrunner B; Bauer D; Paternostro R; Scheiner B; Balcar L; Semmler G; Stättermayer AF; Pinter M; Quehenberger P; Trauner M; Reiberger T; Mandorfer M Clin Gastroenterol Hepatol; 2023 Jul; 21(7):1854-1863.e10. PubMed ID: 36244661 [TBL] [Abstract][Full Text] [Related]
14. Novel serum biomarker of Golgi protein 73 for the diagnosis of clinically significant portal hypertension in patients with compensated cirrhosis. Liu S; Ma J; Chen P; Liu S; Guo Y; Tan M; Guo X; Feng Y; Wang Q; Li W; Yang C; Gao B; Hua Y; Liu N; Song H; He R; Wang R; Gao Q; Liu C; Qi X J Med Virol; 2024 Jan; 96(1):e29380. PubMed ID: 38235849 [TBL] [Abstract][Full Text] [Related]
15. Diagnosis of Clinically Significant Portal Hypertension Using CT- and MRI-based Vascular Model. Wang C; Huang Y; Liu C; Liu F; Hu X; Kuang X; An W; Liu C; Liu Y; Liu S; He R; Wang H; Qi X Radiology; 2023 Apr; 307(2):e221648. PubMed ID: 36719293 [TBL] [Abstract][Full Text] [Related]
16. Plasma Nogo-A and placental growth factor levels are associated with portal hypertension in patients with liver cirrhosis. Gelman S; Salteniene V; Pranculis A; Skieceviciene J; Zykus R; Petrauskas D; Kupcinskas L; Canbay A; Link A; Kupcinskas J World J Gastroenterol; 2019 Jun; 25(23):2935-2946. PubMed ID: 31249451 [TBL] [Abstract][Full Text] [Related]